Malley Thomas
CIK 0001403322
Director
Filings
16
Latest Jun 4, 2026
Issuers covered
3
Showing
16 of 16
Page 1
Track record
4 of 4 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 0% | -9.6% | -10.1% | -5.3% | -12.9% |
| 90 days | 4 | 0% | -18.2% | -20.5% | -9.9% | -21.9% |
| 180 days | 4 | 25% | -23.4% | -33.1% | +7.8% | -35.3% |
| 365 days | 1 | 100% | +92.3% | +92.3% | +92.3% | +92.3% |
Issuers
Companies where Malley Thomas has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals, Ltd. | 7 | Jun 2, 2026 |
| KURA | Kura Oncology, Inc. | 7 | Jun 4, 2026 |
| ONC | Beone Medicines Ltd. | 2 | Jun 20, 2023 |
All filings
16 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|